Category
Services
Modalities
Indications
Phases
Sourcing
Locations
Certifications
Bioanalysis, LC-MS Bioanalysis (Small Molecule), Ligand-Binding Bioanalysis (Large Molecule), Biomarker Assays, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Pharmacovigilance & Drug Safety, Medical Writing, Central Laboratory Services, Clinical Imaging Core Lab, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Cell Therapy, Gene Therapy, Vaccine
Oncology, Immunology, Neurology, Psychiatry, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Dermatology, Ophthalmology, Gastroenterology, Nephrology, Women's Health
Phase II, Phase III, Phase IV, Real-World Evidence (RWE) / Registries
Full-Service Outsourcing (FSO), Functional Service Provider (FSP)
Morrisville, Morrisville, NC, United States, Middleton, Middleton, WI, United States, Cambridge, Cambridge, England, United Kingdom, Sofia, Sofia, Bulgaria, Manila, Manila, Philippines, Mexico City, Mexico City, Mexico, Melbourne, Melbourne, Australia, Bangalore, Bangalore, India, Beijing, Beijing, China
—
Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Pharmacovigilance & Drug Safety, Medical Writing, Central Laboratory Services, Clinical Imaging Core Lab, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Cell Therapy, Gene Therapy, Vaccine
Oncology, Immunology, Neurology, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Dermatology, Ophthalmology, Gastroenterology, Nephrology, Women's Health
Phase I, Phase II, Phase III, Phase IV, Real-World Evidence (RWE) / Registries
Functional Service Provider (FSP), Full-Service Outsourcing (FSO)
Global operations, United States, Headquarters, Durham, NC, United States, Dallas, Dallas, TX, United States, Daytona Beach, Daytona Beach, FL, United States, Madison, Madison, WI, United States, Sydney, Sydney, NSW, Australia, Beijing, Beijing, China, Chengdu, Chengdu, Sichuan, China, Dalian, Dalian, Liaoning, China, Guangzhou, Guangzhou, China, Hangzhou, Hangzhou, Zhejiang, China, Hong Kong, Hong Kong, China, Nanjing, Nanjing, Jiangsu, China, Shanghai, Shanghai, China, Seoul, Seoul, South Korea, Taipei, Taipei, Taiwan, Tokyo, Tokyo, Japan, Raanana, Raanana, Israel, Istanbul, Istanbul, Turkey, Bogotá, Bogotá, Colombia, Buenos Aires, Buenos Aires, Argentina, Lima, Lima, Peru, Mexico City, Mexico City, CDMX, Mexico, Santiago, Santiago, Chile, São Paulo, São Paulo, SP, Brazil, Centurion, Centurion, Gauteng, South Africa, Clinical Research Unit, Dallas, TX, United States, Clinical Research Unit, Daytona Beach, FL, United States, Clinical Research Unit, Madison, WI, United States, Office, São Paulo, SP, Brazil, Office, Mexico City, CDMX, Mexico, Office, Buenos Aires, Argentina, Office, Santiago, Chile, Office, Lima, Peru, Office, Bogotá, Colombia, Office, Centurion, Gauteng, South Africa, Office, Sydney, NSW, Australia, Office, Beijing, China, Office, Shanghai, China, Office, Guangzhou, China, Office, Chengdu, Sichuan, China, Office, Dalian, Liaoning, China, Office, Hangzhou, Zhejiang, China, Office, Nanjing, Jiangsu, China, Office, Hong Kong, China, Office, Tokyo, Japan, Office, Seoul, South Korea, Office, Taipei, Taiwan, Office, Raanana, Israel, Office, Istanbul, Turkey, Office, Herzliya, Israel, Herzliya, Raanana, Israel, Herzliya, Herzliya, Israel, Office, Hong Kong, Hong Kong
cGMP · ID: In-clinic cGMP Pharmacies, FDA · ID: cGMP
Bioanalysis, LC-MS Bioanalysis (Small Molecule), Ligand-Binding Bioanalysis (Large Molecule), Immunogenicity Assays (ADA / NAb), Biomarker Assays, Flow Cytometry Services, Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Pharmacovigilance & Drug Safety, Medical Writing, Central Laboratory Services, Clinical Imaging Core Lab, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy, Translational Research, Companion Diagnostics Development, Immunology & Inflammation Services, Oncology Specialty Services, CNS Specialty Services, Cardiovascular & Metabolic Specialty Services
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Cell Therapy, Gene Therapy, Vaccine
Oncology, Immunology, Neurology, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Ophthalmology, Women's Health
Phase I, Phase II, Phase III, Phase IV, Real-World Evidence (RWE) / Registries
Full-Service Outsourcing (FSO), Functional Service Provider (FSP)
Headquarters, Dublin, Ireland, Belgium, Belgium, Belgium, Bulgaria, Bulgaria, Bulgaria, Germany, Germany, Germany, Hungary, Hungary, Hungary, Italy, Italy, Italy, Netherlands, Netherlands, Netherlands, Poland, Poland, Poland, Romania, Romania, Romania, Slovakia, Slovakia, Slovakia, South Africa, South Africa, South Africa, Spain, Spain, Spain, Türkiye, Türkiye, Türkiye, United Kingdom, United Kingdom, United Kingdom, Australia, Australia, Australia, China, China, China, India, India, India, Japan, Japan, Japan, Korea, Korea, Korea, Malaysia, Malaysia, Malaysia, Taiwan, Taiwan, Taiwan, Argentina, Argentina, Argentina, Brazil, Brazil, Brazil, Chile, Chile, Chile, Colombia, Colombia, Colombia, Mexico, Mexico, Mexico, Belgium, Belgium, Belgium, Bulgaria, Bulgaria, Bulgaria, Germany, Germany, Germany, Hungary, Hungary, Hungary, Italy, Italy, Italy, Netherlands, Netherlands, Netherlands, Poland, Poland, Poland, Romania, Romania, Romania, Slovakia, Slovakia, Slovakia, South Africa, South Africa, South Africa, Spain, Spain, Spain, Türkiye, Türkiye, Türkiye, United Kingdom, United Kingdom, United Kingdom, Australia, Australia, Australia, China, China, China, India, India, India, Japan, Japan, Japan, Korea, Korea, Korea, Malaysia, Malaysia, Malaysia, Taiwan, Taiwan, Taiwan, Argentina, Argentina, Argentina, Brazil, Brazil, Brazil, Chile, Chile, Chile, Colombia, Colombia, Colombia, Mexico, Mexico, Mexico, United States, United States, United States
—
Bioanalysis, Immunogenicity Assays (ADA / NAb), Biomarker Assays, Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Pharmacovigilance & Drug Safety, Medical Writing, Central Laboratory Services, Clinical Imaging Core Lab, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy, Translational Research, Immunology & Inflammation Services, Oncology Specialty Services, CNS Specialty Services, Cardiovascular & Metabolic Specialty Services, Bioinformatics & Data Science
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Cell Therapy, Gene Therapy, Vaccine
Oncology, Immunology, Neurology, Psychiatry, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Dermatology, Ophthalmology, Gastroenterology, Nephrology, Women's Health
Phase I, Phase II, Phase III, Phase IV, Real-World Evidence (RWE) / Registries
Full-Service Outsourcing (FSO), Functional Service Provider (FSP)
Global presence, Multiple, Global presence, Multiple regions, Argentina, Buenos Aires, Buenos Aires, Argentina
—
Showing three peers in the matrix — full ranked list is above.